Manufacturing Services

Nov 13, 2017
By Pharmaceutical Technology Editors
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
Nov 10, 2017
By Pharmaceutical Technology Editors
As part of Recipharm’s ongoing initiative to improve profitability and competitiveness, a decision has been made to end operations in Stockholm and Höganäs.
Nov 02, 2017
Pharmaceutical Technology
Industry experts were honored for business, scientific, and social contributions.
Nov 02, 2017
Pharmaceutical Technology
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.
Nov 02, 2017
By Pharmaceutical Technology Editors
Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.
Oct 25, 2017
By Pharmaceutical Technology Editors
The M&A advisory firm has developed an interactive map of manufacturing sites to give insight into the market size of global manufacturing.
Oct 25, 2017
By Pharmaceutical Technology Editors
Catalent’s new Biologics & Specialty Drug Delivery unit will be led by Barry Littlejohn; Jonathan Arnold to lead Oral Drug Delivery.
Oct 24, 2017
By Pharmaceutical Technology Editors
The CDMO is investing £6 million into a new facility at its United Kingdom site to expand its milling, micronization, and solid form capabilities.
Oct 18, 2017
By Pharmaceutical Technology Editors
The partnership and the formation of the institute intend to bring together industry, academia, and regulators to tackle challenges and provide solutions for continuous manufacturing.
Oct 17, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site
native1_300x100
lorem ipsum